References
- Piel FB, Weatherall DJ. The α-thalassemias. New Engl J Med. 2014;371(20):1908–1916.
- Bhavnani M, Wickham M, Ayyub H, et al. α-Thalassaemia in the north west of England. Clin Lab Hematol. 1989;11(4):293–297.
- Higgs DR, Ayyub H, Clegg JB, et al. α-Thalassaemia in British people. Br Med J. 1985;290(6478):1303–1306.
- Eng B, Greenlay B, Waye JS. Characterisation of the British α0-thalassaemia deletion: evidence of a founder effect in Newfoundland, Canada. Br J Haematol. 2009;147(1):150–152.
- Waye JS, Eng B. Diagnostic testing for α-globin gene disorders in the heterogeneous North American population. Int J Lab Hematol. 2013;35(3):306–313.
- Phylipsen M, Traeger-Synodinos J, van der Kraan, et al. A novel α0-thalassemia deletion in a Greek patient with Hb H disease and β-thalassemia trait. Eur J Haematol. 2012;88(4):356–362.
- Chui DHK, Fucharoen S, Chan V. Hemoglobin H disease: not necessarily a benign disorder. Blood. 2003;101(3):791–800.
- Chui DHK, Waye JS. Hydrops fetalis caused by α-thalassemia: an emerging health care problem. Blood. 1998;91(7):2213–2222.
- Langlois S, Ford JC, Chitayat D, et al. Carrier screening for thalassemia and hemoglobinopathies in Canada. J Obstet Gynaecol Can. 2008;30(10):950–959.